Eli Lilly & Co.
LLYNYSEHealthcare · Pharmaceutical Preparations
Market cap
$896.13B
Employees
50,000
Exchange
NYSE
Headquarters
INDIANAPOLIS, IN
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
LLY news
From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Investing.com · May 21, 2026